---  
layout: startup_page  
title: "Osivax"  
id: "osivax.com"  
permalink: "/osivaxosivax.com03042025/"  
website: "https://osivax.com/"  
funding_round: "Series B"  
funding_amount: "€10M"  
investors: "Meiji Seika Pharma Co., Ltd, Existing Investors"  
about: "Osivax is a clinical-stage biopharmaceutical company developing vaccines using its novel, self-assembling nanoparticle platform technology, oligoDOMTM, to develop transformative, first-in-class pan-respiratory virus vaccines. The company's goal is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of Covid-19 in one single shot."  
markets: "Biotech, Pharmaceuticals, Biotechnology Research"  
hq: "Lyon, France"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/osivax"  
twitter: "https://twitter.com/OsivaxVaccines"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/osivax"  
pitchbook: "https://pitchbook.com/profiles/company/234533-53"  

date_display: "04-Mar-2025"  
date: "2025-03-04"

# SEO Optimization  
meta_title: "Osivax - Series B Funding (€10M)"  
meta_description: "Osivax, Osivax is a clinical-stage biopharmaceutical company developing vaccines using its novel, self-assembling nanoparticle platform technology, oligoDOMTM..."  
meta_keywords: "Osivax, Biotech, Pharmaceuticals, Biotechnology Research, Series B funding"  
canonical_url: "https://startup.projectstartups.com/osivaxosivax.com03042025/"  
---